PNC FINANCIAL SERVICES GROUP, INC. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$113,456
-18.0%
2,467
+2.5%
0.00%
Q2 2023$138,389
+61.9%
2,408
+5.6%
0.00%
Q1 2023$85,502
+28.4%
2,280
-4.0%
0.00%
Q4 2022$66,575
-16.8%
2,376
-17.0%
0.00%
Q3 2022$80,000
+14.3%
2,863
+41.6%
0.00%
Q2 2022$70,000
-4.1%
2,022
+0.2%
0.00%
Q1 2022$73,000
+65.9%
2,017
+4.2%
0.00%
Q4 2021$44,000
+7.3%
1,936
-10.0%
0.00%
Q3 2021$41,000
-12.8%
2,151
-5.9%
0.00%
Q2 2021$47,000
-4.1%
2,287
-16.0%
0.00%
Q1 2021$49,000
+2.1%
2,721
+16.1%
0.00%
Q4 2020$48,000
+20.0%
2,344
+13.1%
0.00%
Q3 2020$40,000
-9.1%
2,073
+5.1%
0.00%
Q2 2020$44,000
+46.7%
1,972
-2.4%
0.00%
Q1 2020$30,000
-42.3%
2,021
-25.8%
0.00%
Q4 2019$52,000
+8.3%
2,725
+13.1%
0.00%
Q3 2019$48,000
-4.0%
2,409
+4.2%
0.00%
Q2 2019$50,000
+11.1%
2,313
+2.3%
0.00%
Q1 2019$45,000
+7.1%
2,262
+3.8%
0.00%
Q4 2018$42,000
+23.5%
2,180
+22.1%
0.00%
Q3 2018$34,000
+161.5%
1,785
+142.9%
0.00%
Q2 2018$13,000
-50.0%
735
-47.5%
0.00%
Q1 2018$26,000
-3.7%
1,399
-1.6%
0.00%
Q4 2017$27,000
+285.7%
1,422
+260.9%
0.00%
Q3 2017$7,000
-99.4%
394
-99.3%
0.00%
-100.0%
Q2 2017$1,082,000
+23.0%
60,521
-0.1%
0.00%0.0%
Q1 2017$880,000
-58.4%
60,611
-47.3%
0.00%
-50.0%
Q4 2016$2,117,000
-4.9%
114,970
-2.1%
0.00%
-33.3%
Q3 2016$2,226,000
+111200.0%
117,392
+112776.9%
0.00%
Q2 2016$2,000
+100.0%
104
-3.7%
0.00%
Q1 2016$1,0000.0%108
+3.8%
0.00%
Q4 2015$1,0000.0%1040.0%0.00%
Q3 2015$1,000
-50.0%
104
+3.0%
0.00%
Q2 2015$2,0001010.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders